Clearbridge Investments, LLC Acadia Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $14,349 - $22,458	-394 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $25,509 - $37,777	-806 Reduced 67.17%	394 $17,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $7,242 - $10,280	200 Added 20.0%	1,200 $49,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $16,170 - $27,380	1,000 New	1,000 $27,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $18,837 - $27,925	-1,250 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $13,420 - $19,570	500 Added 66.67%	1,250 $38,000
Q2 2017 Aug 14, 2017	BUY	N/A	750	750 $21,000

306

157M

828K

317K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.24B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.